Live Breaking News & Updates on Conor Richardson|Page 2

Stay updated with breaking news from Conor richardson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

AUSTIN, TX & DURHAM, NC, April 01, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic. ....

United States , North Carolina , Gil Blum , Taylor Schreiber , Conor Richardson , Shattuck Labs Inc , Annual Needham Virtual Healthcare Conference , Chief Executive , Shattuck Labs , Agonist Redirected Checkpoint , Media Contact ,

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine (AZA) in frontline Highe. ....

United States , North Carolina , Conor Richardson , Mirvetuximab Soravtansine , Taylor Schreiber , American Society Of Hematology , Exchange Commission , Shattuck Labs Inc , Cancer Research , Ono Pharmaceutical Co Ltd , Health Care Conference Boston , Development Rd Expenses , Rna Work In Cancer Research , Higher Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , American Society , Annual Meeting , Chief Executive Officer , Cancer Cell , Milestones Expected , Stage Pipeline , Initial Enrollment , Ongoing Phase , Clinical Trial , Presented Positive Interim Data , Acquired Resistance ,

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine in frontline Higher-Risk Myelodysplastic Syndromes and frontline TP53 mutant. ....

United States , North Carolina , Taylor Schreiber , Conor Richardson , Mirvetuximab Soravtansine , Cancer Research , Rna Work In Cancer Research , Shattuck Labs Inc , Ono Pharmaceutical Co Ltd , Exchange Commission , Development Rd Expenses , Health Care Conference Boston , American Society Of Hematology , Higher Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , American Society , Annual Meeting , Chief Executive Officer , Cancer Cell , Milestones Expected , Stage Pipeline , Initial Enrollment , Ongoing Phase , Clinical Trial , Presented Positive Interim Data , Acquired Resistance ,

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

AUSTIN, TX and DURHAM, NC, Feb. 13, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic. ....

North Carolina , United States , Taylor Schreiber , Conor Richardson , Toichi Takino , Ono Pharmaceutical Co Ltd , Discovery Research Of Ono , Shattuck Labs Inc , Exchange Commission , Ono Pharmaceutical , Chief Executive Officer , Senior Executive , Executive Director , Shattuck Labs , Agonist Redirected Checkpoint , Annual Report , Safe Harbor , Private Securities Litigation Reform Act , Media Contact ,

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

AUSTIN, TX and DURHAM, NC, Jan. 08, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic. ....

United States , North Carolina , San Francisco , Conor Richardson , Taylor Schreiber , Exchange Commission , American Society Of Clinical Oncology , Shattuck Labs Inc , American Society Of Hematology Annual Meeting , Chief Executive Officer , Resistant Ovarian Cancer , American Society , Clinical Oncology , Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , Hematology Annual , Milestones Expected , Financial Guidance , Healthcare Conference , Corporate Presentation , Shattuck Labs , Agonist Redirected Checkpoint , Annual Report , Safe Harbor , Private Securities Litigation Reform Act , Media Contact ,